2023 Was a tricky calendar year with the biopharma field, with various providers downsizing and restructuring their workforces to stay afloat. You'll find signs of Restoration, as mergers and acquisitions picked up over the pharmaceutical and life sciences business while in the latter Section of 2023 and have continued their https://sites.google.com/view/bio-sites/blog